To study the clinical effectiveness and cost-effectiveness of prevaccination testing for hepatitis B virus in adolescents and preadolescents.
Decision analysis model comparing (1) prevaccination testing for hepatitis B surface antibodies, (2) no testing, and (3) testing at the same time as the first vaccine dose.
Sensitivity analyses of the first two strategies were performed varying the seroprevalence of hepatitis B surface antibodies, compliance with follow-up, and costs of testing.
Charges for testing and vaccination were obtained from Children's Hospital and Medical Center in Seattle, Wash.
Vaccination compliance, hepatitis B surface antibodies seroprevalence, and vaccine response rates are from published literature.
Mots-clés Pascal : Vaccination, Washington, Etats Unis, Amérique du Nord, Amérique, Enfant, Homme, Adolescent, Hépatite virale B, Virose, Infection, Anticorps, Prévalence, Antigène HBs, Analyse coût efficacité, Prévention, Foie pathologie, Appareil digestif pathologie, Immunité humorale, Economie santé
Mots-clés Pascal anglais : Vaccination, Washington, United States, North America, America, Child, Human, Adolescent, Viral hepatitis B, Viral disease, Infection, Antibody, Prevalence, Hepatitis B surface antigen, Cost efficiency analysis, Prevention, Hepatic disease, Digestive diseases, Humoral immunity, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0647021
Code Inist : 002B05C02G. Création : 09/06/1995.